Stephens Investment Management Group Has Cut Tyler Technologies (TYL) Stake By $946,050; Shorts at Aethlon Medical (AEMD) Raised By 3.18%

June 29, 2018 - By Ash

Aethlon Medical, Inc. (NASDAQ:AEMD) Logo

Stephens Investment Management Group Llc decreased Tyler Technologies Inc (TYL) stake by 1.92% reported in 2018Q1 SEC filing. Stephens Investment Management Group Llc sold 4,505 shares as Tyler Technologies Inc (TYL)’s stock rose 10.86%. The Stephens Investment Management Group Llc holds 229,599 shares with $48.44 million value, down from 234,104 last quarter. Tyler Technologies Inc now has $8.45B valuation. It closed at $220.68 lastly. It is down 33.03% since June 29, 2017 and is uptrending. It has outperformed by 20.46% the S&P500. Some Historical TYL News: 09/03/2018 – Tyler Technologies Enters Into New, Five-Year Employment Agreements With CEO, President, CFO; 18/04/2018 – TYLER TECHNOLOGIES TO BUY SOCRATA; 10/05/2018 – TYLER TECHNOLOGIES REPORTS CEO TRANSITION; 31/05/2018 – TYLER TECHNOLOGIES INC – UNDER FIVE-YEAR AGREEMENT, FAIRWAY WILL BE TYLER’S SOLE MODRIA PARTNER IN NEW ZEALAND; 30/04/2018 – Tyler Technologies Expands Odyssey Case Management Solution within the Northern Territory of Australia; 02/05/2018 – TYLER TECH 1Q ADJ REV $221.4M, EST. $219.5M; 07/05/2018 – Tyler Tech Presenting at Conference May 24; 18/04/2018 – Tyler Technologies: Expected Closing Date for Socrata is April 30, 2018; 11/05/2018 – Delivering Connected Communities Focus at Tyler Technologies’ Yearly User Conference; 10/05/2018 – TYLER TECHNOLOGIES INC – APPOINTED PRESIDENT, H. LYNN MOORE JR., AS CHIEF EXECUTIVE OFFICER, EFFECTIVE MAY 10, 2018

Aethlon Medical Inc (NASDAQ:AEMD) had an increase of 3.18% in short interest. AEMD’s SI was 1.46M shares in June as released by FINRA. Its up 3.18% from 1.42M shares previously. With 571,700 avg volume, 3 days are for Aethlon Medical Inc (NASDAQ:AEMD)’s short sellers to cover AEMD’s short positions. The stock increased 0.79% or $0.01 during the last trading session, reaching $1.27. About 33,911 shares traded. Aethlon Medical, Inc. (NASDAQ:AEMD) has declined 33.15% since June 29, 2017 and is downtrending. It has underperformed by 45.72% the S&P500. Some Historical AEMD News: 21/03/2018 AETHLON MEDICAL SAYS ON MARCH 20, CO PARTICIPATED IN AN INFORMATIONAL MEETING WITH FDA – SEC FILING; 22/03/2018 – Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoe; 22/03/2018 – Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix; 19/04/2018 – DJ Aethlon Medical Inc, Inst Holders, 1Q 2018 (AEMD); 21/03/2018 – AETHLON – FDA MEETING RESULT OF FORMAL PRE-SUBMISSION REQUEST BY CO FOR DISCUSSING ADVANCEMENT OF AETHLON HEMOPURIFIER (REG) UNDER EAP

Since February 26, 2018, it had 0 insider purchases, and 29 insider sales for $80.76 million activity. MILLER BRIAN K also sold $1.05M worth of Tyler Technologies, Inc. (NYSE:TYL) shares. Shares for $5.75 million were sold by MARR JOHN S JR on Wednesday, June 13. On Tuesday, March 6 Carter Glenn A sold $418,220 worth of Tyler Technologies, Inc. (NYSE:TYL) or 2,000 shares. MOORE H LYNN JR sold $1.82M worth of stock or 8,000 shares. Another trade for 900 shares valued at $204,786 was made by WOMBLE DUSTIN R on Thursday, May 17. On Thursday, March 1 King Luther Jr sold $4.73M worth of Tyler Technologies, Inc. (NYSE:TYL) or 23,350 shares. The insider BRATTAIN DONALD R sold 6,700 shares worth $1.36 million.

Among 8 analysts covering Tyler Technologies (NYSE:TYL), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Tyler Technologies had 13 analyst reports since January 16, 2018 according to SRatingsIntel. The stock of Tyler Technologies, Inc. (NYSE:TYL) has “Buy” rating given on Thursday, April 19 by Benchmark. The firm has “Buy” rating by Needham given on Tuesday, April 24. The stock has “Buy” rating by Northland Capital on Tuesday, April 24. The firm has “Buy” rating given on Monday, June 25 by Piper Jaffray. The firm has “Buy” rating given on Tuesday, March 13 by Robert W. Baird. Needham maintained Tyler Technologies, Inc. (NYSE:TYL) on Thursday, February 22 with “Buy” rating. Piper Jaffray maintained Tyler Technologies, Inc. (NYSE:TYL) on Monday, April 23 with “Buy” rating. As per Monday, March 12, the company rating was downgraded by Evercore. The rating was maintained by Piper Jaffray on Tuesday, January 16 with “Buy”. DA Davidson maintained it with “Neutral” rating and $200 target in Monday, April 23 report.

Investors sentiment increased to 1.21 in 2018 Q1. Its up 0.18, from 1.03 in 2017Q4. It is positive, as 18 investors sold TYL shares while 95 reduced holdings. 51 funds opened positions while 86 raised stakes. 33.94 million shares or 1.21% less from 34.35 million shares in 2017Q4 were reported. Reilly Financial Advisors Limited Liability Corporation stated it has 0.01% of its portfolio in Tyler Technologies, Inc. (NYSE:TYL). New York-based Timessquare Cap Limited Liability has invested 1.13% in Tyler Technologies, Inc. (NYSE:TYL). Employees Retirement System Of Ohio reported 66,731 shares. Gamco Investors Et Al invested 0.15% of its portfolio in Tyler Technologies, Inc. (NYSE:TYL). Schwab Charles Management accumulated 118,030 shares. Tortoise Investment Mgmt Lc has 0% invested in Tyler Technologies, Inc. (NYSE:TYL). Fred Alger Mngmt reported 190,628 shares or 0.19% of all its holdings. Neuberger Berman Grp Ltd Liability has invested 0.34% in Tyler Technologies, Inc. (NYSE:TYL). Tompkins Fincl stated it has 200 shares. Shine Advisory Serv Incorporated owns 307 shares. 112,458 are owned by Eulav Asset Management. Rgm Cap Lc, a Florida-based fund reported 371,999 shares. Suntrust Banks stated it has 18,493 shares or 0.03% of all its holdings. Foundry Partners Limited Liability Corporation owns 0.11% invested in Tyler Technologies, Inc. (NYSE:TYL) for 11,945 shares. The California-based Aperio Gru Lc has invested 0.01% in Tyler Technologies, Inc. (NYSE:TYL).

Stephens Investment Management Group Llc increased Semtech Corp (NASDAQ:SMTC) stake by 12,447 shares to 1.21 million valued at $47.40 million in 2018Q1. It also upped Pioneer Nat Res Co (NYSE:PXD) stake by 2,875 shares and now owns 18,699 shares. Carrizo Oil & Gas Inc (NASDAQ:CRZO) was raised too.

More notable recent Tyler Technologies, Inc. (NYSE:TYL) news were published by: which released: “UPDATE: Tyler Tech (TYL) PT Raised to $260 at Piper Jaffray” on June 25, 2018, also with their article: “Is SS&C Technologies A Buy At Its Current P/E Multiple?” published on June 27, 2018, published: “Tyler Technologies to Provide Mass Appraisal and Tax Software for Anchorage, Alaska” on June 05, 2018. More interesting news about Tyler Technologies, Inc. (NYSE:TYL) were released by: and their article: “Tyler Technologies Announces 2018 Maine App Challenge Winners” published on June 04, 2018 as well as‘s news article titled: “Tyler Technologies and FairWay Resolution Limited Make Online Dispute Resolution a Reality in New Zealand” with publication date: May 31, 2018.

Analysts await Tyler Technologies, Inc. (NYSE:TYL) to report earnings on July, 25. They expect $0.91 EPS, up 5.81% or $0.05 from last year’s $0.86 per share. TYL’s profit will be $34.84M for 60.63 P/E if the $0.91 EPS becomes a reality. After $0.88 actual EPS reported by Tyler Technologies, Inc. for the previous quarter, Wall Street now forecasts 3.41% EPS growth.

More important recent Aethlon Medical, Inc. (NASDAQ:AEMD) news were published by: which released: “Aethlon Medical, Inc. (AEMD) CEO Jim Joyce on Q4 2018 Results – Earnings Call Transcript” on June 08, 2018, also published article titled: “New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business …”, published: “Earnings Scheduled For June 8, 2018” on June 08, 2018. More interesting news about Aethlon Medical, Inc. (NASDAQ:AEMD) was released by: and their article: “Aethlon Medical Announces Fiscal 2018 Results” with publication date: June 08, 2018.

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company has market cap of $22.56 million. The firm is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It currently has negative earnings. It is also involved in the development of exosome products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection.

Tyler Technologies, Inc. (NYSE:TYL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.